CPhI Japan has been postponed due to rising travel restrictions related to the outbreak of COVID-19. The major pharma industry event, which draws in about 200,000 attendees, was scheduled for March 16-18 in Tokyo.
The show’s organizers, Informa Markets, said the decision to delay hosting the event was made after consulting with CPhI’s largest stakeholders, including international exhibitors and major pharmaceutical employees.
“The event is now in its 18th edition and we have always listened to the feedback of our exhibitors,” Christopher Eve, managing director, Informa Markets and UBM Japan, said in a statement. "Due to unforeseen circumstances of COVID-19, many felt that it will be difficult to travel to the exhibition at this time."
Informa Markets said it will work with attendees and exhibitors to determine a new date to hold the event later in the year.
This is the second CPhI event to be impacted by the outbreak of COVID-19. Last week, it was announced that CPhI South East Asia, scheduled for March 4-6 in Thailand has been rescheduled for July 1-3.
CPhI Worldwide, the pharma manufacturing industry’s largest yearly global trade show, is currently scheduled for Oct. 13-15 in Milan, Italy — near a cluster of new COVID-19 cases that has emerged in the last week. This week, the CDC issued a travel warning to Italy and has asked Americans with preexisting conditions to avoid traveling there for the time being.
